DJIA 16,461.32 -153.49 -0.92%
NASDAQ 4,382.85 -36.63 -0.83%
S&P 500 1,927.11 -14.17 -0.73%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)



company name or ticker
Company Photos
(Click to zoom)

Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog

Will Bristol-Myers (BMY) Disappoint This Earnings Season? - Analyst Blog

Stock Picking Grades For Health Care Sector Fund Managers

Is Johnson & Johnson's Worst Nightmare Becoming Reality?

Johnson & Johnson has become a growth story on the back of strong pharmaceutical sales over the past two quarters. This trend looks like it is about to change with the approval of a rival's game-changing drug.

Pacific Biosciences to Incur Narrower-than-Expected Q3 Loss - Analyst Blog

Will BioMarin (BMRN) Disappoint This Earnings Season? - Analyst Blog

Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? - Analyst Blog

Will Biogen Idec (BIIB) Pull a Surprise this Earnings Season? - Analyst Blog

180 Million People Have This Disease, Yet Few Are Aware of It

75% of people with this potentially deadly disease are clueless they have it. Yet the interesting thing is we have the tools needed to practically eradicate it.

Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer - Analyst

Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer - Analyst Blog
See More Articles...